However, the specific role and mechanism of ANOS1 in advanced gastric cancer (GC) and its correlation with epithelial–mesenchymal transition (EMT) are not well understood, despite ongoing research into the expression of ANOS1 and its impact on clinical outcomes. This evidence concerns the gene ANOS1 and gastric cancer.